— Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) reported earnings of $1.70 per share in the fourth-quarter 2019, vs. $1.20 per share expected.
— Total revenue rose 63% to $1.41 billion, vs. $1.01 billion expected.
— For FY20, company expects total product revenues of $5.1 to $5.3 billion.
— VRTX stock ended Thursday’s regular trading session down 0.9%.
Most Popular
CPB Earnings: Key quarterly highlights from Campbell Soup’s Q3 2023 financial results
Campbell Soup Company (NYSE: CPB) reported its third quarter 2023 earnings results today. Net sales increased 5% year-over-year to $2.23 billion. Organic sales also rose 5%. Net earnings attributable to
Key takeaways from J.M. Smucker’s (SJM) Q4 2023 earnings report
Shares of the J.M. Smucker Co. (NYSE: SJM) were down over 2% on Tuesday despite the company beating expectations on its earnings results for the fourth quarter of 2023. The
Oracle (ORCL) looks set to report strong Q4 results next week
After a period of lackluster performance, Oracle Corporation (NYSE: ORCL) got a much-needed boost as the software giant expanded its cloud business aggressively in recent years. The company has outperformed
